World AIDS Day: Understanding HIV December 1 marked World AIDS Day, an international day dedicated to raising awareness of the AIDS pandemic caused by the spread of human immunodeficiency virus (HIV) infection. According to UNAIDS, 37.9 million people globally were...
Squash That Bug The flu. Need we say more? Why yes. Yes, we do! Last week, we examined all things flu: we talked about the influenza virus structure, how the pesky pathogen makes us feel so lousy, and why the vaccine’s effectiveness isn’t always up to sniff, er,...
Influenza: So S’not Funny Happy Flu Season! A throbbing headache, fever, chills—if you’ve ever enjoyed a few days off courtesy of influenza, you’ve got good reason to embrace the simple flu shot. Every year, millions of us roll up our sleeves and take our medicine....
A Breath of fresh air for cystic fibrosis patients It’s not often that a radical treatment for a chronic, often fatal, disease comes around. The WEEKLY takes notice when one does. Vertex Pharmaceuticals’ (Boston, MA) innovative new drug, Trikafta, promises better...
Boo-O-technology! Vampire bats? Zombie cells? Pumpkins that heal? Yes, Halloween has finally encroached on the WEEKLY. Vampire Bats Earlier this year, researchers from the University of Queensland (Brisbane, Australia) published a paper on the possibility that a...
From startups to the Fortune 500, we train employees at companies of all sizes. We offer customized, in-house courses and open enrollment classes. Visit Biotech Primer for more information.
